Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications

被引：0
|
作者：
da Silva, D. Dias [1 ,2 ,3 ]
Brito-da-Costa, A. M. [1 ,2 ,3 ]
Martins, S. Lemos [1 ]
Dinis-Oliveira, R. J. [1 ,2 ,5 ,6 ]
Madureira-Carvalho, A. [1 ,4 ]
机构：
[1] CESPU, Univ Inst Hlth Sci, TOXRUN Toxicol Res Unit, CRL, Gandra, Portugal
[2] Univ Porto, Dept Biol Sci, Lab Toxicol, Fac Pharm,UCIBIO REQUIMTE, Porto, Portugal
[3] Univ Porto, Associate Lab I4HB Inst Hlth & Bioecon, Fac Pharm, Porto, Portugal
[4] Univ Porto, Dept Chem, Lab Pharmacognosy, Fac Pharm,LAQV REQUIMTE, Porto, Portugal
[5] Univ Porto, Dept Publ Hlth & Forens Sci, Fac Med, Porto, Portugal
[6] Univ Porto, Med Educ, Porto, Portugal
来源：
TOXICOLOGY LETTERS | 2022年 / 368卷
基金：
瑞典研究理事会;
关键词：
D O I：
10.1016/j.toxlet.2022.07.283
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P03-21
引用
收藏
页码：S97 / S97
页数：1
相关论文
共 50 条
  • [11] Simultaneous Production of Psilocybin and a Cocktail of β-Carboline Monoamine Oxidase Inhibitors in "Magic" Mushrooms
    Blei, Felix
    Doerner, Sebastian
    Fricke, Janis
    Baldeweg, Florian
    Trottmann, Felix
    Komor, Anna
    Meyer, Florian
    Hertweck, Christian
    Hoffmeister, Dirk
    CHEMISTRY-A EUROPEAN JOURNAL, 2020, 26 (03) : 729 - 734
  • [12] Psilocybin and hallucinogenic mushrooms
    Fradet, Mathieu
    Kelly, Carlton M.
    Donnelly, Anna J.
    Suppes, Trisha
    CNS SPECTRUMS, 2024, 29 (06) : 611 - 632
  • [13] Will psilocybin lose its magic in the clinical setting?
    Hayes, Caroline
    Wahba, Mourad
    Watson, Stuart
    THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, 2022, 12
  • [14] Clinical applications of fentanyl pharmacokinetics and pharmacodynamics: Roles of fentanyl in anesthesia
    Shibutani K.
    Katoh T.
    Sakai T.
    Komatsu T.
    Sawada K.
    Frost E.A.M.
    Journal of Anesthesia, 1999, 13 (4) : 209 - 216
  • [15] S-Adenosyl-l-Methionine Salvage Impacts Psilocybin Formation in "Magic" Mushrooms
    Demmler, Richard
    Fricke, Janis
    Doerner, Sebastian
    Gressler, Markus
    Hoffmeister, Dirk
    CHEMBIOCHEM, 2020, 21 (09) : 1364 - 1371
  • [16] Clinical Pharmacokinetics and Pharmacodynamics of Micafungin
    Wasmann, Roeland E.
    Muilwijk, Eline W.
    Burger, David M.
    Verweij, Paul E.
    Knibbe, Catherijne A.
    Bruggemann, Roger J.
    CLINICAL PHARMACOKINETICS, 2018, 57 (03) : 267 - 286
  • [17] Clinical Pharmacokinetics and Pharmacodynamics of Dabrafenib
    Puszkiel, Alicja
    Noe, Gaelle
    Bellesoeur, Audrey
    Kramkimel, Nora
    Paludetto, Marie-Noelle
    Thomas-Schoemann, Audrey
    Vidal, Michel
    Goldwasser, Francois
    Chatelut, Etienne
    Blanchet, Benoit
    CLINICAL PHARMACOKINETICS, 2019, 58 (04) : 451 - 467
  • [18] Clinical Pharmacokinetics and Pharmacodynamics of Rucaparib
    Mingxiang Liao
    Jeri Beltman
    Heidi Giordano
    Thomas C. Harding
    Lara Maloney
    Andrew D. Simmons
    Jim J. Xiao
    Clinical Pharmacokinetics, 2022, 61 : 1477 - 1493
  • [19] Clinical Pharmacokinetics and Pharmacodynamics of Isepamicin
    Michel Tod
    Christophe Padoin
    Olivier Petitjean
    Clinical Pharmacokinetics, 2000, 38 : 205 - 223
  • [20] Clinical Pharmacokinetics and Pharmacodynamics of Dalbavancin
    Kyle C. Molina
    Matthew A. Miller
    Scott W. Mueller
    Edward T. Van Matre
    Martin Krsak
    Tyree H. Kiser
    Clinical Pharmacokinetics, 2022, 61 : 363 - 374
12345